This is not a buy recommendation, Put on watch. P
Post# of 22755
Pronai Therapeutics Com USD0. ($DNAI)
$ 2.07 ▼-4.31 (-67.55%)
Volume: 12,329,487
ProNAi Therapeutics Inc. (DNAI) said it would discontinue development of its lymphoma treatment following disappointing Phase 2 trial results. The company said that while "modest efficacy" was observed, the trial results were not robust enough to justify continued development of the drug. Shares of ProNAi fell 65% to $2.25, which is down from its initial public offering price of $17 and its all-time high of $33.75.
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'